Joint Pharmaceutical Co., Ltd.

Verification Opinion on the List of Initial Grantees for the 2026 Restricted Stock Incentive Plan by the Compensation and Assessment Committee

Legal Opinion on the Initial Grant of Restricted Stock Incentive Plan for Hubei Joint Pharmaceutical Co., Ltd. 2026

Announcement on the Initial Grant of Restricted Stock under the 2026 Incentive Plan

Announcement of Resolutions from the 14th Meeting of the 3rd Board of Directors

List of Initial Grantees for the 2026 Restricted Stock Incentive Plan

Pre-Disclosure Announcement on Shareholders Holding More than 5%, Directors Reducing Shares

Self-inspection report on the trading of company stocks by insiders of the 2026 restricted stock incentive plan

Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

Legal Opinion from Beijing Zhonglun (Wuhan) Law Firm Regarding the 2025 Annual Shareholders' Meeting of Hubei Gongtong Pharmaceutical Co., Ltd.

The Remuneration and Assessment Committee of the Board of Directors' Explanation and Verification Opinion on the List of Incentive Objects for the 2026 Restricted Stock Incentive Plan

Announcement on Holding the 2025 Annual Performance Briefing

Announcement of the Resolution of the 13th Meeting of the Third Board of Directors

Announcement on the Proposed Change of Company Name and Amendment of the Articles of Association

Legal Opinion from Beijing Zhonglun (Wuhan) Law Firm on the Cancellation of Certain Granted but Unvested Restricted Stocks from Hubei Gongtong Pharmaceutical Co., Ltd.'s 2023 Restricted Stock Incentive Plan

Announcement on the Cancellation of Certain Granted but Unvested Restricted Stocks from the 2023 Restricted Stock Incentive Plan

Legal Opinion from Beijing Zhonglun (Wuhan) Law Firm on Hubei Gongtong Pharmaceutical Co., Ltd. 2026 Restricted Stock Incentive Plan

Board Remuneration and Assessment Committee's Verification Opinion on the Company's 2026 Restricted Stock Incentive Plan

2026 Restricted Stock Incentive Plan Self-Inspection Form

Hubei Gongtong Pharmaceutical Co., Ltd. 2026 Restricted Stock Incentive Plan Implementation Assessment Management Measures

Hubei Gongtong Pharmaceutical Co., Ltd. 2026 Restricted Stock Incentive Plan (Draft)

Hubei Gongtong Pharmaceutical Co., Ltd. 2026 Restricted Stock Incentive Plan (Draft) - Summary

Announcement on Requesting Shareholder Authorization for the Board to Issue Stocks to Specific Objects via Simplified Procedures

Announcement on the Disclosure of the 2025 Annual Report

2025 Annual Board Work Report

2025 Annual Financial Settlement Report

Announcement on the Proposed Reappointment of Accounting Firm

Independent Director's Annual Work Report for 2025 (He Deliang)

Independent Director's Annual Work Report for 2025 (Long Ziwu)

Independent Director's Annual Work Report for 2025 (Qi Fei)

Internal Control Audit Report

Internal Control Evaluation Report

Temporary Suspension and Exemption Management System for Information Disclosure

Remuneration Management System for Directors and Senior Management

Announcement on the Remuneration Plan for Directors and Senior Management

Company Articles of Association

Announcement on the Company's Provision for Asset Impairment and Credit Impairment for 2025

Announcement on the Company's and Subsidiaries' Application for Comprehensive Credit Limits and Provision of Guarantees to Financial Institutions for 2026

Notice of the 2025 Annual Shareholders' Meeting

Announcement of the Resolution of the 13th Meeting of the Third Board of Directors

Announcement on the Profit Distribution Plan for the Company for 2025

Q1 2026 Report

Special Audit Report on Operating Revenue Deductions

Evaluation Report on the Accounting Firm's Performance for 2025

Report of the Board Audit Committee on the Evaluation of the Accounting Firm's Performance and Supervisory Duties for 2025

Special Audit Report on the Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions

Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions for 2025

Board's Special Opinion on the Self-Examination of Independent Directors' Independence

2025 Annual Audit Report

2025 Annual Report

Summary of the 2025 Annual Report

Announcement of the Resolutions of the Twelfth Meeting of the Third Board of Directors

Announcement on Not Lowering the Conversion Price of the Joint Convertible Bonds

Notice on the expected triggering of downward adjustment conditions for the conversion price of convertible bonds

Announcement on the conversion of convertible corporate bonds in the first quarter of 2026

Announcement on the Company's Estimated Daily Related Party Transactions for 2026

Resolutions Announcement of the 11th Meeting of the Third Board of Directors